A Registry Study of NanoKnife IRE for Stage 3 Pancreatic Cancer

Clinical trial NCT03899649 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT03899649
Sponsor: Angiodynamics, Inc.
Status: ACTIVE_NOT_RECRUITING
Study type: OBSERVATIONAL

Stage III Pancreatic Cancer

Start date: 2019-05-08
Primary completion: 2025-04-01
Enrollment: 532

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.